Express Scripts Holding Company
Express Scripts Holding Company Fundamental Analysis
Express Scripts Holding Company (ESRX) shows moderate financial fundamentals with a PE ratio of 11.86, profit margin of 4.51%, and ROE of 26.30%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 63.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze ESRX's fundamental strength across five key dimensions:
Efficiency Score
WeakESRX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentESRX trades at attractive valuation levels.
Growth Score
WeakESRX faces weak or negative growth trends.
Financial Health Score
ModerateESRX shows balanced financial health with some risks.
Profitability Score
WeakESRX struggles to sustain strong margins.
Key Financial Metrics
Is ESRX Expensive or Cheap?
P/E Ratio
ESRX trades at 11.86 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ESRX's PEG of 0.12 indicates potential undervaluation.
Price to Book
The market values Express Scripts Holding Company at 2.96 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -1.87 times EBITDA. This is generally considered low.
How Well Does ESRX Make Money?
Net Profit Margin
For every $100 in sales, Express Scripts Holding Company keeps $4.51 as profit after all expenses.
Operating Margin
Core operations generate 5.49 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $26.30 in profit for every $100 of shareholder equity.
ROA
Express Scripts Holding Company generates $8.33 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $8.76 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
11.86
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.12
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.96
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.88
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.67
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.26
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How ESRX Stacks Against Its Sector Peers
| Metric | ESRX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 11.86 | 29.43 | Better (Cheaper) |
| ROE | 26.30% | 800.00% | Weak |
| Net Margin | 4.51% | -20145.00% (disorted) | Weak |
| Debt/Equity | 0.88 | 0.30 | Weak (High Leverage) |
| Current Ratio | 0.67 | 4.64 | Weak Liquidity |
| ROA | 8.33% | -17936.00% (disorted) | Weak |
ESRX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Express Scripts Holding Company's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation